Decheng Capital Management III (Cayman), LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 260 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
Decheng Capital Management III (Cayman), LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$12,223,331
-37.2%
1,463,8720.0%4.08%
-33.2%
Q2 2023$19,469,498
+14.9%
1,463,8720.0%6.11%
-10.7%
Q1 2023$16,951,638
+41.6%
1,463,8720.0%6.84%
+52.6%
Q4 2022$11,974,473
+40.8%
1,463,8720.0%4.48%
+45.3%
Q3 2022$8,505,000
+31.5%
1,463,8720.0%3.08%
+25.7%
Q2 2022$6,470,000
-51.4%
1,463,8720.0%2.45%
-39.9%
Q1 2022$13,321,0001,463,8724.08%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2023
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,446,459$48,182,0007.22%
BOURNE LENT ASSET MANAGEMENT INC 536,800$17,881,0005.70%
Casdin Capital, LLC 5,000,000$166,550,0004.96%
Iron Triangle Partners LP 935,805$31,172,0003.96%
Jackson Square Partners, LLC 12,911,695$430,088,0002.44%
SB Management Ltd 9,861,089$328,473,0002.12%
Abacus Planning Group, Inc. 180,000$5,996,0001.92%
BERKSHIRE CAPITAL HOLDINGS INC 413,800$13,784,0001.57%
ARK Investment Management 21,301,191$709,543,0001.41%
Nikko Asset Management Americas, Inc. 5,247,237$174,785,0000.86%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders